4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Bradyarrhythmia in 2 studies
4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, MT | 1 |
Chueh, FY | 1 |
Hsieh, MT | 1 |
Chen, CF | 1 |
N'Diaye, A | 1 |
Sévoz-Couche, C | 1 |
Nosjean, A | 1 |
Hamon, M | 1 |
Laguzzi, R | 1 |
2 other studies available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Bradyarrhythmia
Article | Year |
---|---|
Antihypertensive effects of DL-tetrahydropalmatine: an active principle isolated from Corydalis.
Topics: Amphetamines; Analysis of Variance; Animals; Antihypertensive Agents; Berberine Alkaloids; Blood Pre | 1996 |
Stimulation of 5-HT2 receptors in the nucleus tractus solitarius enhances NMDA receptor-mediated reflex-evoked bradycardiac responses in the rat.
Topics: 2-Amino-5-phosphonovalerate; Amphetamines; Anesthesia; Animals; Blood Pressure; Bradycardia; Chemore | 2001 |